KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Emergent BioSolutions (EBS) Shares Issued (2016 - 2026)

Emergent BioSolutions has reported Shares Issued over the past 17 years, most recently at $400000.0 for Q1 2026.

For Q1 2026, Shares Issued rose 300.0% year-over-year to $400000.0; the TTM value through Mar 2026 reached $300000.0, down 97.78%, while the annual FY2024 figure was $13.4 million, 644.44% up from the prior year.
Shares Issued for Q1 2026 was $400000.0 at Emergent BioSolutions, up from -$1.0 million in the prior quarter.
Over five years, Shares Issued peaked at $13.4 million in Q4 2024 and troughed at -$8.2 million in Q3 2023.
A 5-year average of $1.1 million and a median of $450000.0 in 2022 define the central range for Shares Issued.
Biggest five-year swings in Shares Issued: plummeted 188.24% in 2022 and later surged 644.44% in 2024.
Year by year, Shares Issued stood at -$3.0 million in 2022, then skyrocketed by 160.0% to $1.8 million in 2023, then surged by 644.44% to $13.4 million in 2024, then plummeted by 107.46% to -$1.0 million in 2025, then skyrocketed by 140.0% to $400000.0 in 2026.
Business Quant data shows Shares Issued for EBS at $400000.0 in Q1 2026, -$1.0 million in Q4 2025, and $200000.0 in Q3 2025.